register

News & Trends - Biotechnology

NSW leads the way in gene and cell therapy

Health Industry Hub | December 17, 2019 |

A $25 million NSW Government facility will give patients with genetic diseases, cancers and viral infections across Australia faster access to ground-breaking trial therapies.

Minister for Health and Medical Research Brad Hazzard, Minister for Jobs, Investment, Tourism and Western Sydney, Stuart Ayres and Member for Parramatta Geoff Lee today announced the NSW Government is investing $25 million to build an advanced viral vector manufacturing facility at the Westmead Health and Innovation Precinct.

“A global shortage in manufacture of viral vectors and plasmids – key components of gene and cell therapies – has led to a two year wait worldwide,” Mr Hazzard said.

“This facility will produce clinical grade viral vectors on our home ground, significantly cutting waiting times for patients across Australia to give them the best health outcomes.”

NSW Health’s Western Sydney Local Health District and Sydney Children’s Hospitals Network have partnered with the University of Sydney to establish the facility.

Mr Ayres said the Westmead Health Precinct is one of the largest health, education, research and training precincts in Australia and a key provider of jobs for the greater Parramatta and Western Sydney region.

“The NSW Government will seek to unlock the opportunities within the Westmead Health and Innovation Precinct in order to grow sectors and industries, like gene and cell therapies, which have the potential to attract a significant number of jobs, spur innovation and help to save lives and cure diseases.”

Mr Lee said the manufacturing facility is not only a tremendous boost for Parramatta but will reinforce NSW’s position as a global leader in developing gene and cell therapies.

“Parramatta will proudly house the manufacturing hub for new treatments for diseases such as spinal muscular atrophy, the leading genetic cause of infant death in Australia,” Mr Lee said.In 2019-20, the NSW Government is investing $108 million in medical and scientific innovation, including further support for researchers in this area.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

Differentiate your business, build thought leadership and boost network growth by reaching the Australian Pharma, MedTech and Biotech industry professionals. Health Industry Hub offers unique solutions to vendors and suppliers servicing the industry.


Human Resources

The return-to-office debate: Where are we in the pendulum's swing?

The return-to-office debate: Where are we in the pendulum’s swing?

Health Industry Hub | May 24, 2024 |

People & Culture: The evolution of hybrid and flexible workplaces has yielded mixed results across the healthcare sector, with some […]

More


News & Trends - MedTech & Diagnostics

Cardinal Health launches local facility for reprocessing of single-use medical devices

Cardinal Health launches local facility for reprocessing of single-use medical devices

Health Industry Hub | May 24, 2024 |

MedTech & Diagnostics News: Cardinal Health is set to launch a cutting-edge facility in Australia dedicated to the reprocessing of […]

More


Medical

New ophthalmic centre to partner on pharma and medtech clinical trials

New ophthalmic centre to partner on pharma and medtech clinical trials

Health Industry Hub | May 24, 2024 |

Medical: The Victorian Deputy Premier and Minister for Medical Research, the Hon Ben Carroll, has launched a cutting-edge ophthalmic clinical […]

More


News & Trends - Pharmaceuticals

Private sector, government and academia gather to tackle barriers in vaccine value chain

Private sector, government and academia gather to tackle barriers in vaccine value chain

Health Industry Hub | May 24, 2024 |

Pharma News: An ‘invite only’ vaccine thought leadership event, aimed at addressing gaps in Australia’s vaccine ecosystem and maximising the […]

More


This content is copyright protected. Please subscribe to gain access.